Latest Insider Transactions at Nektar Therapeutics (NKTR)
This section provides a real-time view of insider transactions for Nektar Therapeutics (NKTR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NEKTAR THERAPEUTICS to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NEKTAR THERAPEUTICS's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2025
|
Howard W Robin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
21,667
+22.2%
|
-
|
|
Dec 22
2025
|
Jonathan Zalevsky Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+19.86%
|
-
|
|
Nov 25
2025
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
630
-2.84%
|
$34,020
$54.28 P/Share
|
|
Nov 25
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
1,157
-5.75%
|
$62,478
$54.28 P/Share
|
|
Nov 25
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
2,207
-3.91%
|
$119,178
$54.28 P/Share
|
|
Nov 21
2025
|
Mark Andrew Wilson Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,903
+7.89%
|
-
|
|
Nov 21
2025
|
Jonathan Zalevsky Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,666
+11.7%
|
-
|
|
Nov 21
2025
|
Howard W Robin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,110
+11.19%
|
-
|
|
Sep 09
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
6,666
-3.11%
|
$306,636
$46.81 P/Share
|
|
Sep 05
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
6,666
-3.67%
|
$253,308
$38.86 P/Share
|
|
Sep 04
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
5,166
-1.96%
|
$175,644
$34.03 P/Share
|
|
Sep 04
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
1,721
-2.32%
|
$58,514
$34.03 P/Share
|
|
Sep 02
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-2.16%
|
$45,000
$30.16 P/Share
|
|
Sep 02
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
485
-2.47%
|
$14,550
$30.1 P/Share
|
|
Aug 19
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
725
-3.56%
|
$18,850
$26.59 P/Share
|
|
Aug 19
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
1,573
-2.22%
|
$40,898
$26.59 P/Share
|
|
Aug 19
2025
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
676
-3.22%
|
$17,576
$26.59 P/Share
|
|
May 19
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
23,208
-2.14%
|
$0
$0.67 P/Share
|
|
May 19
2025
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,996
-3.08%
|
$0
$0.67 P/Share
|
|
May 19
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
10,712
-3.38%
|
$0
$0.67 P/Share
|
|
Feb 19
2025
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,040
-3.29%
|
$11,040
$1.01 P/Share
|
|
Feb 19
2025
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
10,300
-3.15%
|
$10,300
$1.01 P/Share
|
|
Feb 19
2025
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
23,774
-2.14%
|
$23,774
$1.01 P/Share
|
|
Dec 24
2024
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
16,560
-4.71%
|
$0
$0.89 P/Share
|
|
Dec 23
2024
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
33,402
-8.67%
|
$0
$0.9 P/Share
|
|
Dec 19
2024
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
51,115
-13.52%
|
$0
$0.94 P/Share
|
|
Dec 18
2024
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
85,035
-7.11%
|
$0
$0.99 P/Share
|
|
Dec 17
2024
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
46,995
-3.78%
|
$46,995
$1.01 P/Share
|
|
Dec 13
2024
|
Mark Andrew Wilson Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
165,938
+30.1%
|
-
|
|
Dec 13
2024
|
Jonathan Zalevsky Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+26.31%
|
-
|
|
Dec 13
2024
|
Howard W Robin President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
410,625
+24.84%
|
-
|
|
Nov 19
2024
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
16,278
-1.92%
|
$16,278
$1.01 P/Share
|
|
Nov 19
2024
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,407
-2.84%
|
$6,407
$1.01 P/Share
|
|
Nov 19
2024
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
7,785
-3.1%
|
$7,785
$1.01 P/Share
|
|
Aug 19
2024
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,651
-2.45%
|
$5,651
$1.28 P/Share
|
|
Aug 19
2024
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
6,866
-2.66%
|
$6,866
$1.28 P/Share
|
|
Aug 19
2024
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
14,881
-1.72%
|
$14,881
$1.28 P/Share
|
|
Jun 14
2024
|
Robert Chess |
SELL
Open market or private sale
|
Direct |
19,500
-7.1%
|
$19,500
$1.2 P/Share
|
|
May 17
2024
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,260
-2.65%
|
$6,260
$1.75 P/Share
|
|
May 17
2024
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
7,355
-2.78%
|
$7,355
$1.75 P/Share
|
|
May 17
2024
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
16,650
-1.89%
|
$16,650
$1.75 P/Share
|
|
May 10
2024
|
Deep Track Capital, LP |
SELL
Open market or private sale
|
Indirect |
56,000
-0.3%
|
$56,000
$1.78 P/Share
|
|
Feb 20
2024
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
20,033
-2.23%
|
$0
$0.68 P/Share
|
|
Feb 20
2024
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,606
-3.11%
|
$0
$0.68 P/Share
|
|
Feb 20
2024
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
9,014
-3.29%
|
$0
$0.68 P/Share
|
|
Nov 17
2023
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,179
-2.86%
|
$0
$0.49 P/Share
|
|
Nov 17
2023
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
9,646
-3.4%
|
$0
$0.49 P/Share
|
|
Nov 17
2023
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
19,877
-2.16%
|
$0
$0.49 P/Share
|
|
Sep 18
2023
|
Myriam Curet Director |
SELL
Open market or private sale
|
Direct |
4,359
-13.72%
|
$0
$0.69 P/Share
|
|
Sep 18
2023
|
Jeffrey Robert Ajer |
SELL
Open market or private sale
|
Direct |
4,359
-11.32%
|
$0
$0.69 P/Share
|